GNF179 is a potent, small molecule antagonist of the GPR55 G-protein coupled receptor, a target currently under investigation for its role in calcium signaling and neuroprotection. As a compound in preclinical… Read more
GNF179 is a potent, small molecule antagonist of the GPR55 G-protein coupled receptor, a target currently under investigation for its role in calcium signaling and neuroprotection. As a compound in preclinical development, GNF179 is being evaluated for potential therapeutic applications in managing neurological disorders and inflammatory conditions. For laboratories engaged in the analytical development and study of this compound, high-quality reference standards are essential. This category provides access to critical materials, including specific metabolites used for impurity profiling and structural characterization. Additionally, stable isotope labelled compounds like the 13C2-labelled metabolite serve as high-precision internal standards in mass spectrometry assays. These materials are fundamental for researchers conducting bioanalysis, method validation, and rigorous quality control, enabling the accurate identification and quantification of GNF179 and its derivatives throughout the drug development process.